Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma: A useful marker of invasive growth

American Journal of Clinical Pathology

Volumn 125, Issue 6, 2006, Pages 847-854

  Rapa, Ida ^a   Volante, Marco ^a   Cappia, Susanna ^a   Rosas, Rosj ^a   Scagliotti, Giorgio V ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cathepsin K; Immunohistochemistry; Invasion; Lung adenocarcinoma; Stroma

Indexed keywords

CATHEPSIN K;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG FIBROBLAST; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TUMOR CELL;

EID: 33744502621     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/Q96AYDAAJ3E1TNWT     Document Type: Article

References (20)

1. World Health Organization. Histological Typing of Lung Tumours. Geneva, Switzerland: World Health Organization; 1967.
2. Travis WD, Colby TV, Corrin B, et al. Histological Typing of Lung and Pleural Tumours. 3rd ed. Berlin, Germany: Springer; 1999. World Health Organisation International Histological Classification of Tumours.
3. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004. World Health Organisation Classification of Tumours.
4. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279-3287.
5. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer. 1995;75:2844-2852.
6. Laskin JJ, Sandler AB, Johnson DH. Redefining bronchioloalveolar carcinoma. Semin Oncol. 2005;32:329-335.
7. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004;28:198-206.
8. Eto T, Suzuki H, Honda A, et al. The changes of the stromal elastotic framework in the growth of peripheral lung adenocarcinomas. Cancer. 1996;77:646-656.
9. Maeshima AM, Niki T, Maeshima A, et al. Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma. Cancer. 2002;95:2546-2554.
10. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol. 2003;27:937-951.
11. Kitamura H, Oosawa Y, Kawano N, et al. Basement membrane patterns, gelatinase A and tissue inhibitor of metalloproteinase-2 expressions, and stromal fibrosis during the development of peripheral lung adenocarcinoma. Hum Pathol. 1999;30:331-338.
12. Kumaki F, Matsui K, Kawai T, et al. Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia. Am J Pathol. 2001;159:2125-2135.
13. Buhling F, Rocken C, Brasch F, et al. Pivotal role of cathepsin K in lung fibrosis. Am J Pathol. 2004;164:2203-2216.
14. Buhling F, Reisenauer A, Gerber A, et al. Cathepsin K; a marker of macrophage differentiation? J Pathol. 2001;195:375-382.
15. Buhling F, Gerber A, Hackel C, et al. Expression of cathepsin K in lung epithelial cells. Am J Respir Cell Mol Biol. 1999;20:612-619.
16. Littlewood-Evans AJ, Bilbe G, Bowler WB, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 1997;57:5386-5390.
17. Brubaker KD, Vessella RL, True LD, et al. Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res. 2003;18:222-230.
18. Tanaka F, Otake Y, Yanagihara K, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res. 2001;7:3410-3415.
19. Tanaka F, Ishikawa S, Yanagihara K, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res. 2002;62:7124-7129.
20. Zhu L, Moreira AL, Yim J. Lung adenocarcinoma with mixed subtype, a distinct biologic entity [abstract]? Mod Pathol. 2005;18(S1):322.